Radiation therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)
IJROBP Journal SA-CME activity for July 15, 2018 (Volume 101, Issue 4) provides radiation oncologists with evidence based guidelines in the management of Solitary Bone Plasmacytoma and Solitary Extramedullary Plasmacytoma and Multiple Myeloma.
Please click here to read the related journal article online.
This activity is available from June 14, 2018 through 11:59 p.m. Eastern time on June 13, 2020.
This program is designed to meet the interest of radiation oncologists, radiation oncology residents, and nurses.
- Discuss updated data and guidelines for treatment options for multiple myeloma and plasmacytoma.
- Describe recommended radiotherapy doses and fields for multiple myeloma and plasmacytoma for palliative and definitive cases.
- Perform appropriate workup and discuss treatment options and post-treatment follow-up for multiple myeloma and plasmacytoma.
Brandi Page, MD is employed by Johns Hopkins University has no financial relationships with a commercial interest.
Richard Tsang, MD is employed by Princess Margaret Hospital has no financial relationships with a commercial interest.
Anthony Zietman, MD, FASTRO is employed by Massachusetts General Hospital and Elsevier, receives compensation/remuneration/funding from the National Cancer Institute (NCI) and holds leadership positions at ABR and NCI.
The person(s) above served as the developer(s) of this activity. Additionally, the Journal CME Task Force and CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $30
- Member: $25
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.